The combination of MEK inhibitor + hydroxychloroquine( plaquenil) ± bevacizumab: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
9
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal Cancer Recurrent | 1 |
| Colorectal cancer | 1 |
| Lung Cancer | 1 |
| Melanoma | 1 |
| Pancreas Cancer | 1 |
| Pancreatic cancer | 1 |
| RAS Mutation | 1 |
| Ras (Kras or Nras) Gene Mutation | 1 |
| Refractory Cancer | 1 |
Recruiting trials involving The combination of MEK inhibitor + hydroxychloroquine( plaquenil) ± bevacizumab
Common questions
How many recruiting trials involve The combination of MEK inhibitor + hydroxychloroquine( plaquenil) ± bevacizumab?
1 recruiting trial across 9 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.